Titan Medical Inc (TMDIF)

[BelizeMe]

Everyone keeps valuing this robot with Medtronic like they don’t already own 30% of it. That will get subtracted off any BO offer. So again, $2 billion valuation minus 1/3 of IP already paid for by MDT comes down to $1.3 B and around nine bucks a share. Woo hoo.

If you were in the medical device industry and in hospitals you would realize that the intuitive SP robot makes up less than 5% of their capital and disposable business.

Robots that have sold for $3.5 B and up we’re robots that would handle the entire amount of indications for the procedures.
In other words, Auris doesn’t need a second robot to come in and handle the more complex indications. Same with the Mazor spine robot.

Enos may be more efficient at certain procedures but will be unable to perform some more complex procedures due to only having two arms. It will be a very good device for outpatient and GYN procedures with the small footprint and flexible arms, but you will not see very many hospitals purchase this robot before the Hugo. And the amount of hospitals that have both MP and SP robots is very small due to cost.

My point is, all these things come in play in a valuation. When the Enos robot would make up at best 25% of sales between the MP an SP robots for MDT in hospitals that wouldn’t bring a top valuation of $4-$5 B as the revenue it will bring in pales in comparison to the multi port.

BelizeMe